Oncoscience

Volume 5: Issue 9-10

pp252-266

Issue 9-10

About the Cover

The cover for this issue of Oncoscience features Figure 1 from "TP53 mutation status: emerging biomarker for precision radiation medicine?" Willers et al.

Research Perspectives

Re-thinking preclinical models of cancer metastasis

https://doi.org/10.18632/oncoscience.450

Maria F. Ullo, Jeremy S. Logue

p 252-253

PDF

Targeting PIM kinases to oppose hypoxia-mediated therapeutic resistance

https://doi.org/10.18632/oncoscience.458

Shailender S. Chauhan, Noel A. Warfel

p 254-255

PDF

Risks and chances of aberrant DNA repair in cancer

https://doi.org/10.18632/oncoscience.459

Maria  Schubert, Richard  Greil, Rol  Geisberger

p 256-257

PDF

TP53 mutation status: emerging biomarker for precision radiation medicine?

https://doi.org/10.18632/oncoscience.468

Henning  Willers, Meng  Wang, Cyril H. Benes

p 258-259

PDF

ETV4: an emerging target in pancreatic cancer

https://doi.org/10.18632/oncoscience.471

Sachin Kumar Deshmukh, Ajay P. Singh, Seema  Singh

p 260-261

PDF

Reply to: Biological role of miR-204 and miR-211 in melanoma (published in Oncoscience, Vol 5 (7-8), July 2018)

https://doi.org/10.18632/oncoscience.473

Marta  Díaz-Martínez, Lucía  Benito-Jardón, Lola  Alonso, Joaquin  Teixidó

p 262-263

PDF

Research Papers

Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment

https://doi.org/10.18632/oncoscience.472

Dana C. Galván, Anoop P. Ayyappan, Brad A. Bryan

p 264-268

Abstract |  PDF |  Full Text